3RD QUARTER 2021
Reporting
Evonik has published its quarterly report Q3 2021 on November 4, 2021.You can access further information here.
- Q3 with adj. EBITDA of €645 m continuing on strong Q2 level despite ~€30 m negative temporary & one-time effects
- Price increases gaining track: Q3 at +8% in growth divisions (Q2: +2%)
- Cost inflation managed well and compensated by price increases already in Q3
- Sustained positive trends into Q4 – FY EBITDA outlook specified to ~€2.4 bn (top end of prev. range)
- Record strong FCF of €937 m in 1-9 2021 – FY FCF outlook raised to ~€1 bn
- Growth drivers in place & cost inflation under control – Set for continued structural growth in FY 2022
Reporting 3rd Quarter 2021
|
Document
|
Link / PDF
|
|
Analyst & Investor Factsheet
|
|
|
Presentation Conference Call
|
|
|
Detailed overview of key financial data (Evonik Financials) - as PDF |
|
|
Detailed overview of key financial data (Evonik Financials) - as Excel |
|
|
Quarterly Statement Q3 2021 |
|
|
Investor Relations News Q3 2021 |
|
|
Analysts' consensus* (Vara Research) |
|
|
Webcast Conference Call Q3-Reporting |
* The consensus is not controlled, changed or censored by Evonik Industries AG. Evonik Industries AG assumes no liability for the accuracy and completeness of these estimates and undertakes no obligation to update or revise such estimates and consensus data, even if they differ from Evonik Industries AG’s own forecasts or expectations. Evonik Industries AG is neither involved in the collection of the data, nor in the preparation of the consensus. This is done independently by Vara Research.